ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Synthetic Biology: Emerging Global Markets Published on November 2011
Report Summary REPORT SCOPE INTRODUCTION STUDY GOAL AND OBJECTIVES BCC's goal for this study is to determine the specific applications and forecast global market demand for synthetic biology products over a 5-year period from 2011 to 2016. Our particular interest is to characterize and quantify the synthetic biology products market potential by product type and end use market segments. We also analyze the synthetic biology industry structure, competitors, and intellectual property landscape. Synthetic biology markets reviewed in this report include enabling products, biologic components, integrated systems, and enabled products. Our key objective is to present a comprehensive analysis of the emerging synthetic biology industry, with an emphasis on products and technologies that are commercially important in the 2011-to-2016 time period. Market segments with rapid growth rates are highlighted, as well as those segments with large market potential. This analysis provides a quantitative basis and market context for companies to make strategic choices about participation in the synthetic biology industry. The study will be particularly useful to companies supplying synthetic genes, oligonucleotides, DNA sequencing instruments, cell culture media, biofuels, specialty chemicals, pharmaceuticals, vaccines, microfluidics, and life sciences tools. REASONS FOR DOING THE STUDY Synthetic biology is a rapidly emerging biotechnology discipline with a wide range of applications. Despite its emerging status, synthetic biology provides a significant number of near-term commercial opportunities, and the list of new products and applications is continuously growing. These applications include specialty chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms. It is important for companies in industries affected by the developments in synthetic biology to sort through the many potential applications to identify near-term commercial opportunities for product development focus. This report allows companies to prioritize product opportunities, establishing a solid framework for strategic planning. Synthetic biology encompasses a wide range of industries including life science tools, biotechnology, pharmaceuticals, diagnostics, energy, and chemicals. Because of its wide scope, synthetic biology plays an important role in the future of the industrial economy. Ongoing advances in enabling technologies such as DNA synthesis and sequencing, specialty media, and bioinformatics, as well as a need for renewable feedstocks, are driving the growth of synthetic biology. Rapid developments in these multidisciplinary fields promise to advance the synthetic biology industry and create unique market opportunities. This report analyzes these trends and their impact on the future markets for synthetic biology products.
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 1/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Based on these market and technology dynamics, it is especially timely to examine the current and future synthetic biology markets. INTENDED AUDIENCE We have compiled a study of existing and future synthetic biology products and technologies that will be commercially important in the main end user segments of life science research, pharmaceuticals, diagnostics, energy, chemicals, and agriculture. We present markets by end use segment (R&D, diagnostics/pharmaceuticals, energy, chemicals, and agriculture) and by product type (enabling products, biologic components, integrated systems, and enabled products). Key market segments are covered, including synthetic genes, chassis organisms, biofuels, specialty chemicals, and pharmaceuticals. We analyze synthetic biology technologies, growth driving forces, market applications, industry structure and competitive dynamics, companies and industry alliances, future market potential, and product sales forecasts for the period 2011 through 2016. We project the future use of synthetic biology products in the main end user segments and by product type. This report will be of particular interest to pharmaceuticals, chemicals, enzymes, energy, agricultural, biotechnology, and bionanobiotechnology companies, as well as suppliers of genomics tools, DNA synthesis, and DNA sequencing products. It will also be of high interest to professionals within governments and regulatory agencies to understand the scope and pace of synthetic biology technologies as they reach the market. SCOPE AND FORMAT The study's scope includes core synthetic biology products (synthetic genes, other DNA parts, chassis organisms, synthetic cells), enabling technologies (DNA sequencing, oligonucleotides, specialty media, bioinformatics), and enabled technologies (biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture) that are already commercial or forecast to be commercialized within the next 5 years. We analyze key synthetic biology technologies and products to determine present and future market status, and forecast growth from 2011 through 2016. We also discuss strategic alliances, industry structures, competitive dynamics, patent strategy, and market driving forces. BCC examines the synthetic biology industry by market segment, including suppliers of synthetic genes, enzymes, pharmaceutical companies, biofuels, and specialty chemicals. The role of key strategic alliances from 2009 through 2011 is discussed. Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, and chassis organisms are analyzed, as well as metabolically-engineered factories for producing synthetic fuels and specialty chemicals. The main companies in these fields are highlighted. METHODOLOGY BCC surveys key users and producers in each of the end user market segments and technology fields that will be commercially important during the next 5 years. Discussions with industry thought leaders, as well as secondary market research was performed. Based on our analysis, we project the future applications of synthetic biology technologies in the major end user market segments and by technology type, and forecast sales revenues for 2011 through 2016. INFORMATIION SOURCES BCC surveyed leading synthetic biology, biotechnology, pharmaceutical, chemical, and energy companies to obtain data for this
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 2/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! study. Included were life science research tools, drug, biotechnology, DNA synthesis and sequencing, and microfluidics firms, as well as leading life science research institutions. We also obtained inputs from leading academic and industry thought leaders. Data from secondary sources included industry, trade, and government publications.
Table of Content Table of Contents CHAPTER ONE: INTRODUCTION 1 STUDY GOALS AND OBJECTIVES 1 REASONS FOR DOING THE STUDY 1 INTENDED AUDIENCE 2 SCOPE AND FORMAT 3 METHODOLOGY 3 INFORMATION SOURCES 3 RELATED BCC REPORTS 4 ANALYST CREDENTIALS 4 BCC ON-LINE SERVICES 4 DISCLAIMER 4 DISCLAIMER (CONTINUED) 5 CHAPTER TWO: SUMMARY 6 SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 6 SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, 2010-2016 ($ MILLIONS) 7 SUMMARY (CONTINUED) 8 CHAPTER THREE: OVERVIEW 9 SYNTHETIC BIOLOGY TECHNOLOGIES COVERED IN THIS REPORT 9 TABLE 1 SCOPE OF THIS REPORT 9 FIGURE 1 SYNTHETIC BIOLOGY VALUE-ADDED CHAIN 10 WHAT IS SYNTHETIC BIOLOGY' 10 DEVELOPMENT STAGE OF SYNTHETIC BIOLOGY 11 FIGURE 2 FROM THE NATURAL TO THE ARTIFICIAL 12 FORCES DRIVING SYNTHETIC BIOLOGY MARKET GROWTH 13 TABLE 2 FORCES DRIVING THE GROWTH OF SYNTHETIC BIOLOGY 13 GLOBAL MARKET POTENTIAL FOR SYNTHETIC BIOLOGY PRODUCTS 14 TABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY END USER INDUSTRY, THROUGH 2016 ($ MILLIONS) 15 LIFE CYCLE STATUS OF PRODUCTS AND TECHNOLOGIES 15 TABLE 4 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE 16 THE SYNTHETIC BIOLOGY INDUSTRY 17
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 3/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! TABLE 5 SYNTHETIC BIOLOGY COMPETITORS BY MARKET FOCUS 17 CHAPTER FOUR: SYNTHETIC BIOLOGY TECHNOLOGIES 18 INTRODUCTION 18 SYNTHETIC BIOLOGY DEFINED 18 TABLE 6 SYNTHETIC BIOLOGY DEFINITIONS 18 HISTORY OF SYNTHETIC BIOLOGY 19 TABLE 7 SYNTHETIC BIOLOGY HISTORY 19 TABLE 7 (CONTINUED) 20 History of Synthetic Biology (Continued) 21 PARADIGM SHIFT IN BIOLOGY 22 TABLE 8 PARADIGM SHIFT CAUSED BY SYNTHETIC BIOLOGY 22 TABLE 9 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARISON 23 Paradigm Shift In Biology (Continued) 24 FIGURE 3 SCALE OF SYNTHETIC BIOLOGY (BASE PAIRS) 25 SYNTHETIC BIOLOGY TECHNOLOGY OVERVIEW 26 TABLE 10 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY 26 ENABLING TECHNOLOGIES 27 TABLE 11 IMPORTANCE OF ENABLING TECHNOLOGIES 27 DNA SYNTHESIS AND SEQUENCING COST TRENDS 28 TABLE 12 COSTS TO SEQUENCE AND SYNTHESIZE A HUMAN GENOME, 2001-2018 28 DNA SYNTHESIS TECHNOLOGIES 29 FIGURE 4 SCHEMATIC OF GENE SYNTHESIS TECHNOLOGIES 29 DNA Synthesis Technologies (Continued) 30 TABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIES 31 PCR-based Approaches 31 Solid-phase Approaches 32 MICROFLUIDICS TECHNOLOGIES 33 TABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY 33 DNA Microarrays ' Oligos Synthesis 33 TABLE 15 MICROARRAY TYPES 34 TABLE 16 DNA MICROARRAY PLATFORM FEATURES 34 TABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR MANUFACTURERS 35 TABLE 17 (CONTINUED) 36 DNA Microarrays ' ' (Continued) 37 FIGURE 5 MICROARRAYS IN GENE SYNTHESIS 38 DNA SEQUENCING TECHNOLOGIES 39 TABLE 18 WORKFLOW COMPARISON OF SELECTED NEXTGENERATION DNA SEQUENCING PLATFORMS 39 TABLE 19 BIOCHIP CONTENT IN NEXT-GENERATION SEQUENCING MACHINES 40 DNA Sequencing Technologies (Continued) 41 BIOINFORMATICS TECHNOLOGIES 42 TABLE 20 SYNTHETIC BIOLOGY BIOINFORMATICS
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 4/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! TECHNOLOGIES 43 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIES 43 TABLE 21 NUCLEIC ACIDS, GENES, AND GENOMES 44 SYNTHETIC GENES 44 TABLE 22 SYNTHETIC GENES AS A MOLECULAR BIOLOGY TOOL 45 TABLE 23 SYNTHETIC GENES VERSUS PCR CLONING 46 Synthetic Genes (Continued) 47 BIOBRICK PARTS 48 TABLE 24 BIOBRICK PARTS 48 Biobrick Parts (Continued) 49 FIGURE 6 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY SYSTEMS 50 MINIMAL GENOMES AND CHASSIS ORGANISMS 51 TABLE 25 ATTRIBUTES OF A MINIMAL GENOME 51 Case Study: Minimal E coli Genome 52 Role of Directed Evolution in Designing Biologic Parts 53 ENABLED TECHNOLOGIES 53 TABLE 26 ENABLED TECHNOLOGIES: EXISTING AND NEAR TERM APPLICATIONS 54 PATHWAY ENGINEERING 54 FIGURE 7 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS 55 TABLE 27 METABOLIC ENGINEERING FOR ARTEMISINIC ACID 56 SYNTHETIC MICROBIAL CONSORTIA 57 TABLE 28 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA 58 RESEARCH AND DEVELOPMENT APPLICATIONS 59 TABLE 29 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS 59 BIOFUELS TECHNOLOGIES 60 OVERVIEW 60 TABLE 30 ADVANCED BIOFUELS TYPES 61 FIRST AND SECOND GENERATION BIOFUELS TECHNOLOGIES 62 TABLE 31 FIRST AND SECOND GENERATION BIOFUELS COMPARED 62 CROP FEEDSTOCKS 63 TABLE 32 ENERGY BALANCE OF SELECTED FIRST GENERATION BIOFUEL FEEDSTOCKS 64 CELLULOSIC FEEDSTOCKS 64 TABLE 33 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%) 64 TABLE 34 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSIC BIOMASS INTO ETHANOL 65 TABLE 35 BIOMASS ECONOMICS 66 ALGAE FEEDSTOCKS 66 TABLE 36 BIODIESEL YIELDS OF SELECTED CROPS 67
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 5/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! CARBON DIOXIDE FEEDSTOCKS 68 BIOFUEL END PRODUCTS 68 TABLE 37 EFFICIENCIES OF VARIOUS FUELS 69 Cellulosic Ethanol 69 FIGURE 8 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC 70 Biodiesel 71 TABLE 38 IODINE NUMBER OF VARIOUS OILS 72 Other Biofuels 72 Role of Genetic Engineering and Synthetic Biology in Biofuels 73 TABLE 39 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS 73 Role of Genetic Engineering and ' (Continued) 74 CHAPTER FIVE: SYNTHETIC BIOLOGY APPLICATIONS 75 INTRODUCTION 75 ENABLING TECHNOLOGIES APPLICATIONS 75 TABLE 40 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING TECHNOLOGIES 75 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS APPLICATIONS 76 TABLE 41 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONS 76 SYNTHETIC GENE APPLICATIONS 77 TABLE 42 SYNTHETIC GENES NEAR-TERM APPLICATIONS 77 Synthetic Gene Applications (Continued) 78 BIOBRICK PARTS APPLICATIONS 79 Biobrick Parts Applications (Continued) 80 INTEGRATED SYSTEMS APPLICATIONS 81 TABLE 43 E COLI AS A CHASSIS ORGANISM 81 Integrated Systems Applications (Continued) 82 Synthetic Cells and Tissues 83 Cellular Factories 83 ENABLED PRODUCT APPLICATIONS 83 PHARMACEUTICALS 84 TABLE 44 SYNTHETIC BIOLOGY-ENABLED DRUG CLASSES 84 TABLE 45 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS 85 TABLE 46 SYNTHETIC BIOLOGY-ENABLED PHARMACEUTICAL APPLICATIONS 86 Pharmaceuticals (Continued) 87 DIAGNOSTICS 88 TABLE 47 SYNTHETIC BIOLOGY-ENABLED DIAGNOSTICS APPLICATIONS 88 BIOFUELS 89 TABLE 48 SYNTHETIC BIOLOGY-ENABLED BIOFUELS APPLICATIONS 89 TABLE 49 GROWTH STATUS OF SPECIALTY VERSUS DROP-IN BIOFUELS, 2000-2020 90 CHEMICALS 90
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 6/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! TABLE 50 SYNTHETIC BIOLOGY-ENABLED CHEMICALS APPLICATIONS 90 TABLE 50 (CONTINUED) 91 ENGINEERED PLANTS AND INSECTS 91 TABLE 51 SYNTHETIC BIOLOGY-ENABLED ENGINEERED PLANTS AND INSECTS APPLICATIONS 92 PRODUCTION PROCESSES 92 TABLE 52 SYNTHETIC BIOLOGY-ENABLED PRODUCTION PROCESSES APPLICATIONS 93 CHAPTER SIX: SYNTHETIC BIOLOGY INDUSTRY 94 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN 94 FIGURE 9 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC BIOLOGY LEVERAGE POINTS 95 INDUSTRY STRUCTURAL FORCES 96 TABLE 53 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES 96 INDUSTRY STRUCTURAL FORCES (CONTINUED) 97 PRODUCTS AND TECHNOLOGY LIFE CYCLE 98 TABLE 54 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGES 98 GENE SYNTHESIS INDUSTRY 99 GENE SYNTHESIS WORKFLOW 99 TABLE 55 GENE SYNTHESIS WORKFLOW 99 Gene Synthesis Workflow (Continued) 100 GENE SYNTHESIS COMPETITORS 101 TABLE 56 SYNTHETIC GENE COMPANY ESTIMATED 2010 MARKET SHARES ($ MILLIONS/%) 102 Gene Synthesis Competitors (Continued) 103 TABLE 57 SYNTHETIC GENE KEY COMPETITOR STRATEGIES 104 GENE SYNTHESIS VALUE CHAIN 105 SYNTHETIC GENE MARKET SEGMENTS 106 Automated Standardized Segment 107 Value Added Segment 107 TABLE 58 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION 108 BIOFUELS INDUSTRY 109 COMPETITIVE DIFFERENTIATION 109 FEEDSTOCKS 109 TABLE 59 BIOFUELS: FEEDSTOCKS, PRODUCTION AND PRODUCTS 110 TABLE 60 BIOFUELS FEEDSTOCKS: RELATIVE SUPPLY VOLUME AND COSTS 111 Sugars/Starches 111 Vegetable Oils 111 Biomasses 111 Algae 112 CO2 112 BIOFUEL COMPETITOR STRATEGIES 112 TABLE 61 SYNTHETIC BIOLOGY BIOFUELS COMPANY
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 7/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! STRATEGIES 113 TABLE 61 (CONTINUED) 114 Biofuel Competitor Strategies (Continued) 115 Biofuel Competitor Strategies (Continued) 116 Biofuel Competitor Strategies (Continued) 117 CHEMICALS INDUSTRY 118 TABLE 62 SYNTHETIC BIOLOGY-ENABLED CHEMICALS APPLICATIONS 118 TABLE 63 VALUE-ADDED IN SELECTED END MARKETS 119 ENZYMES INDUSTRY 120 TABLE 64 ENZYME COMPANY KEY ALLIANCES 120 TABLE 64 (CONTINUED) 121 PHARMACEUTICALS INDUSTRY 122 TABLE 65 SYNTHETIC BIOLOGY-ENABLED DRUG STRATEGIES 122 TABLE 65 (CONTINUED) 123 ACQUISITIONS AND STRATEGIC ALLIANCES 124 TABLE 66 SYNTHETIC BIOLOGY INDUSTRY ACQUISITIONS, 2010' 2011 125 Acquisitions and Strategic Alliances (Continued) 126 Acquisitions and Strategic Alliances (Continued) 127 TABLE 67 STRATEGIC ALLIANCES, 2009'2011 128 TABLE 67 (CONTINUED) 129 TABLE 67 (CONTINUED) 130 TABLE 67 (CONTINUED) 131 Acquisitions and Strategic Alliances (Continued) 132 Acquisitions and Strategic Alliances (Continued) 133 Acquisitions and Strategic Alliances (Continued) 134 Acquisitions and Strategic Alliances (Continued) 135 Acquisitions and Strategic Alliances (Continued) 136 Acquisitions and Strategic Alliances (Continued) 137 Acquisitions and Strategic Alliances (Continued) 138 CHAPTER SEVEN: SYNTHETIC BIOLOGY MARKETS 139 INDUSTRY GROWTH DRIVING FORCES 139 TABLE 68 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES 139 INDUSTRY GROWTH DRIVING FORCES (CONTINUED) 140 MACROECONOMIC FORECASTING ASSUMPTIONS 141 FIGURE 10 MARKET FORECAST SCENARIO TABLE 142 SYNTHETIC BIOLOGY MARKETS BY END USER INDUSTRY 143 TABLE 69 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY END USER INDUSTRY, THROUGH 2016 ($ MILLIONS) 143 R&D MARKET 144 TABLE 70 GLOBAL VALUE OF R&D MARKET, BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 144 DIAGNOSTICS AND PHARMACEUTICALS MARKET 145 TABLE 71 GLOBAL VALUE OF DIAGNOSTICS/PHARMACEUTICALS MARKET, BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 145 Diagnostics and Pharmaceuticals Market (Continued) 146 CHEMICALS MARKET 147
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 8/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! TABLE 72 GLOBAL VALUE OF CHEMICALS MARKET, BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 148 ENERGY MARKET 148 TABLE 73 GLOBAL VALUE OF ENERGY MARKET, BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 149 AGRICULTURE MARKET 149 TABLE 74 GLOBAL VALUE OF AGRICULTURE MARKET, BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 150 SYNTHETIC BIOLOGY MARKETS BY PRODUCT TYPE 150 SUMMARY 150 TABLE 75 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 151 ENABLING PRODUCTS MARKETS 152 TABLE 76 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLING PRODUCTS, BY TYPE, THROUGH 2016 ($ MILLIONS) 152 TABLE 77 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLING PRODUCTS, BY INDUSTRY, THROUGH 2016 ($ MILLIONS) 153 BIOLOGIC COMPONENTS MARKET 154 TABLE 78 GLOBAL VALUE OF BIOLOGIC COMPONENTS MARKET, BY TYPE, THROUGH 2016 ($ MILLIONS) 155 Synthetic Gene Standardized Market Segment 155 Synthetic Gene Value-added Market Segment 155 TABLE 79 GLOBAL VALUE OF BIOLOGIC COMPONENTS MARKET, BY INDUSTRY, THROUGH 2016 ($ MILLIONS) 156 Synthetic Gene Value-' (Continued) 157 INTEGRATED SYSTEMS MARKET 158 TABLE 80 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONS 158 TABLE 81 GLOBAL VALUE OF INTEGRATED SYSTEMS MARKET, BY TYPE, THROUGH 2016 ($ MILLIONS) 158 Integrated Systems Market (Continued) 159 TABLE 82 GLOBAL VALUE OF INTEGRATED SYSTEMS MARKET, BY INDUSTRY, THROUGH 2016 ($ MILLIONS) 160 ENABLED PRODUCTS MARKET 160 SOURCES OF COMPETITIVE ADVANTAGE 160 TABLE 83 BIODIESEL FUEL PERFORMANCE COMPARISON 161 TABLE 84 ARTEMISININ DRUG PRODUCTION COMPARISON 162 TABLE 85 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLED PRODUCTS MARKET, BY INDUSTRY, THROUGH 2016 ($ MILLIONS) 162 DIAGNOSTICS AND PHARMACEUTICALS MARKET 163 TABLE 86 GLOBAL VALUE OF ENABLED DIAGNOSTIC AND PHARMACEUTICALS MARKET, BY INDUSTRY, THROUGH 2016 ($ MILLIONS) 164 TABLE 87 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED DIAGNOSTICS MARKET, BY INDICATION, THROUGH 2016 ($ MILLIONS) 164 TABLE 88 GLOBAL VALUE OF ENABLED PHARMACEUTICALS
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 9/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! MARKET, BY DRUG CLASS, THROUGH 2016 ($ MILLIONS) 165 Diagnostics and Pharmaceuticals Market (Continued) 166 CHEMICALS MARKET 167 TABLE 89 GLOBAL VALUE OF ENABLED CHEMICALS MARKET, BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 168 BIOFUELS MARKET 169 TABLE 90 ADVANCED BIOFUEL GROWTH DRIVING FACTORS 170 TABLE 91 PUBLIC AND PRIVATE FUNDING FOR SELECTED BIOFUELS COMPANIES 171 TABLE 92 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED BIOFUELS MARKET, BY FUEL TYPE, THROUGH 2016 ($ MILLIONS) 172 AGRICULTURE MARKET 173 TABLE 93 GLOBAL VALUE OF AGRICULTURE MARKET, BY APPLICATION, THROUGH 2016 ($ MILLIONS) 173 ALL PRODUCTS BY GEOGRAPHY 174 TABLE 94 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY GEOGRAPHY, THROUGH 2016 ($ MILLIONS) 175 ENABLING PRODUCTS MARKET BY GEOGRAPHY 176 TABLE 95 GLOBAL VALUE OF ENABLING PRODUCTS MARKET, BY GEOGRAPHY, THROUGH 2016 ($ MILLIONS) 176 CORE PRODUCTS BY GEOGRAPHY 176 TABLE 96 GLOBAL VALUE OF CORE PRODUCTS MARKET, BY GEOGRAPHY, THROUGH 2016 ($ MILLIONS) 177 ENABLED PRODUCTS BY GEOGRAPHY 177 TABLE 97 GLOBAL VALUE OF ENABLED PRODUCTS MARKET, BY GEOGRAPHY, THROUGH 2016($ MILLIONS) 178 Enabled Products by Geography (Continued) 179 CHAPTER EIGHT: PATENTS 180 INTRODUCTION 180 TABLE 98 SYNTHETIC BIOLOGY PATENT SCOPE 181 FOUNDATIONAL PATENTS 181 TABLE 99 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS 182 Enabled Products by Geography (Continued) 183 SYNTHETIC BIOLOGY INDUSTRY PATENT ANALYSIS 184 FIGURE 11 NUMBER OF PATENTS BY COMPANY 185 FIGURE 11 (CONTINUED) 186 FIGURE 12 PATENTS BY COMPANY AND SUBCLASS 187 FIGURE 12 (CONTINUED) 188 TABLE 100 PATENT DESCRIPTION BY COMPANY 189 TABLE 100 (CONTINUED) 190 PATENT STRATEGY OF SELECTED COMPANIES 191 METABOLIX 191 DUPONT 191 GENEART (LIFE TECHNOLOGIES) 192 FEBIT 192 BIOTICA 193 CHAPTER NINE: COMPANY PROFILES 194
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 10/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! AGRIVIDA 194 TABLE 101 AGRIVIDA TECHNICAL APPROACH 194 ALGENICS 195 ALGENOL BIOFUELS 196 ALLOPARTIS BIOTECHNOLOGIES, INC 196 ALLYLIX 197 AMBRX, INC 197 AMYRIS BIOTECHNOLOGIES, INC 198 TABLE 102 AMYRIS SPECIALTY CHEMICALS STRATEGY 199 TABLE 103 AMYRIS BIODIESEL ADVANTAGES 200 ATG BIOSYNTHETICS GMBH 201 BASF AG 202 BAYER AG 203 BIOAMBER INC 203 BIOBASIC INC 204 BIOCALDOL LTD 204 BIOCAT GMBH 204 BIONEER CORPORATION 205 BIONEXUS INC 206 BIOSEARCH TECHNOLOGIES, INC 206 BIO S&T, INC 207 BIOTICA TECHNOLOGY LTD 207 BIOTICA TECHNOLOGY LTD (CONTINUED) 208 TABLE 104 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCIN 209 BLUE MARBLE ENERGY 210 BRISTOL MYERS SQUIBB 210 BRISTOL MYERS SQUIBB (CONTINUED) 211 BRITISH PETROLEUM 212 COBALT TECHNOLOGIES 213 CODEXIS, INC 214 DANISCO A/S 215 DNA20 216 DNA20 (CONTINUED) 217 DOW CHEMICAL COMPANY 218 DRATHS CORPORATION 218 DRATHS CORPORATION (CONTINUED) 219 EI DU PONT DE NEMOURS AND COMPANY 220 EI DU PONT DE NEMOURS '(CONTINUED) 221 DYADIC INTERNATIONAL 222 ENTELECHON GMBH 222 EPOCH LIFE SCIENCE, INC 223 EUROFINS MWG OPERON 224 EVOLVA SA 224 TABLE 105 EVOLVA'S GENETIC CHEMISTRY PLATFORM 225 TABLE 106 EVOLVA STRATEGIC ALLIANCES 226 TABLE 107 EVOLVA PRODUCT PIPELINE 226 EXXONMOBIL CORPORATION 227 FEBIT HOLDING GMBH 228
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 11/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! FLUXOME A/S 229 GENEMED SYNTHESIS INC 229 GENEWORKS PTY LTD 230 GENEORACLE, INC 230 GENOMATICA 230 GENSCRIPT USA INC 231 GEVO, INC 232 GINKGO BIOWORKS 233 GLYCOS BIOTECHNOLOGIES, INC 234 GOODYEAR TIRE & RUBBER 234 GREEN BIOLOGICS LTD 235 ILLUMINA, INC 235 ILLUMINA, INC (CONTINUED) 236 INGENZA LTD 237 INTEGRATED DNA TECHNOLOGIES, INC 238 INSTITUTE FOR ONEWORLD HEALTH 238 IOGEN CORPORATION 239 INTREXON CORPORATION 239 TABLE 108 INTREXON ULTRAVECTOR PARTS INVENTORY EXAMPLES 240 JOULE UNLIMITED 241 KIVERDI, INC 242 LC SCIENCES 242 LIFE TECHNOLOGIES, INC 243 LIFE TECHNOLOGIES, INC (CONTINUED) 244 LS9, INC 245 LUMINEX 246 MASCOMA 247 MERCK & CO 248 METABOLIX INC 248 TABLE 109 MIREL'S COMPETITORS IN BIOPLASTICS 249 METRIGEN, INC 250 MODULAR GENETICS 250 MORPHOSYS AG 250 MYRIANT TECHNOLOGIES 251 NEW ENGLAND BIOLABS 252 NOVACTA BIOSYSTEMS LTD 253 NOVOZYMES A/S 253 OMEGA BIO-TEK, INC 254 OPX BIOTECHNOLOGIES, INC 255 ORIGENE TECHNOLOGIES 256 OXITEC LTD 256 PACIFIC BIOSCIENCES 257 PFIZER 258 PROTERRO INC 259 PROTOLIFE SRL 260 QTEROS, INC 260 RENNOVIA, INC 261
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 12/15
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! ROCHE LIFE SCIENCES 261 ROYAL DSM NV 262 SANGAMO BIOSCIENCES, INC 263 TABLE 110 SANGAMO STRATEGIC ALLIANCES 264 SANGAMO BIOSCIENCES, INC (CONTINUED) 265 SANOFI AVENTIS 266 SAPPHIRE ENERGY 267 SCARAB GENOMICS, LLC 267 SHANGHAI GENERAY BIOTECH CO, LTD 268 SHANGHAI SHINEGENE MOLECULAR BIO-TECHNOLOGIES, INC 268 SOLAZYME, INC 269 TABLE 111 SOLAZYME STRATEGIC ALLIANCES 270 SUTRO BIOPHARMA, INC 271 SWITCHGEAR GENOMICS 271 SYNPROMICS LTD 272 SYNTHETIC GENOMICS INC 272 SYNTHETIC GENOMICS INC (CONTINUED) 273 TABLE 112 SYNTHETIC GENOMICS STRATEGIC ALLIANCES 274 THERMO FISHER SCIENTIFIC 275 VERDEZYNE, INC 275 VERENIUM CORPORATION 276 VERENIUM CORPORATION (CONTINUED) 277 VIRAL GENETICS INC 278 ZIOPHARM ONCOLOGY, INC 278 ZIOPHARM ONCOLOGY, INC (CONTINUED) 279
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 13/15
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Synthetic Biology: Emerging Global Markets
Product Formats Please select the product formats and the quantity you require.
1 User License--USD 4 850.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Synthetic Biology: Emerging Global Markets (From Issuu)
Page 14/15
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Synthetic Biology: Emerging Global Markets (From Issuu)
Asia, Oceania and America : + 1 (805) 617 17 93
Page 15/15